Baxter International sells kidney care unit to Carlyle Group for $3.8B, focusing on core businesses.
Baxter International sells its kidney care unit to Carlyle Group for $3.8 billion in a deal expected to strengthen both companies' positions in the dialysis market and provide better access to care for kidney patients. Baxter will utilize the proceeds to focus on its core businesses, including hospital and home-based IV therapies and pharmaceuticals. The transaction is pending regulatory approvals and customary closing conditions.
August 13, 2024
5 Articles